In a report published Wednesday, Canaccord Genuity reiterated its Buy rating on Monsanto Company (NYSE: MON), and raised its price target from $104.00 to $113.00. Canaccord Genuity noted, “From an industry viewpoint, we continue to expect another record planting in the US this spring, followed by a further record planting in Latin America next fall,